|
|
|
Polio virus There are three serotypes (1-3) It was the most common causes of flaccid paralysis 2-3 decades ago. Transmission Transmission is through faecal-oral route Incubation period Incubation period-1 to 2 weeks. Infectious period- 3 days before the onset of illness to 1 week after the onset.
Clinical presentations
Prodromal Phase Acute onset of fever, malaise.
Aseptic meningitis Vomiting, fever, headache and stiff neck. May experience spastic type of paralysis and increased deep tendon reflex.
Paralytic phase Flaccid paralysis It only affects the motor neuron (Muscle tone and tendon reflex are reduced)
Complications Ø Bulbar poliomyelitis Ø Deformity of the lower limb Ø Disability
Investigation Tests Stools, pharyngeal swab and CSF Virus isolation- cell culture Identification is done by acid labile testing and neutralisation test.
Management
Most isolates are vaccine strains. They do not cause problems in immunocompetent patients. Wild strains if isolated should be reported to the communicable disease control centres. There is no specific treatment however immunocompromised patients with persistent wild or vaccine strains polio virus infection might benefit from therapy with human normal immunoglobulin or piloconaril (antiviral) Symptomatic therapy is essential to reduce disability and deformity of the bone.
Prevention
There is an effective vaccine. Inactivated polio vaccine is advocated by many expertise although attenuated polio vaccine was used to eradicate the virus from a number of countries. Safe and clean water supply and proper disposal of waste are the corner stone of controlling any water borne infection.
|
|
Date this page is updated: 04/03/2007 23:13:30 www. virologynotebook.co.uk
|